These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
355 related items for PubMed ID: 12097494
1. In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis. Cao G, Pei W, Ge H, Liang Q, Luo Y, Sharp FR, Lu A, Ran R, Graham SH, Chen J. J Neurosci; 2002 Jul 01; 22(13):5423-31. PubMed ID: 12097494 [Abstract] [Full Text] [Related]
2. Protection against ischemic brain injury by protein therapeutics. Asoh S, Ohsawa I, Mori T, Katsura K, Hiraide T, Katayama Y, Kimura M, Ozaki D, Yamagata K, Ohta S. Proc Natl Acad Sci U S A; 2002 Dec 24; 99(26):17107-12. PubMed ID: 12475933 [Abstract] [Full Text] [Related]
3. TAT-mediated delivery of Bcl-xL protein is neuroprotective against neonatal hypoxic-ischemic brain injury via inhibition of caspases and AIF. Yin W, Cao G, Johnnides MJ, Signore AP, Luo Y, Hickey RW, Chen J. Neurobiol Dis; 2006 Feb 24; 21(2):358-71. PubMed ID: 16140540 [Abstract] [Full Text] [Related]
4. Intravenous TAT-Bcl-Xl is protective after middle cerebral artery occlusion in mice. Kilic E, Dietz GP, Hermann DM, Bähr M. Ann Neurol; 2002 Nov 24; 52(5):617-22. PubMed ID: 12402259 [Abstract] [Full Text] [Related]
5. Neuroprotective effect of TAT-14-3-3ε fusion protein against cerebral ischemia/reperfusion injury in rats. Zhu Y, Bu Q, Liu X, Hu W, Wang Y. PLoS One; 2014 Nov 24; 9(3):e93334. PubMed ID: 24671253 [Abstract] [Full Text] [Related]
6. Neuroprotective effect of TAT PTD-Ngb fusion protein on primary cortical neurons against hypoxia-induced apoptosis. Zhou G, Shan P, Hu X, Zheng X, Zhou S. Neurol Sci; 2013 Oct 24; 34(10):1771-8. PubMed ID: 23456442 [Abstract] [Full Text] [Related]
9. Mild hypothermia enhanced the protective effect of protein therapy with transductive anti-death FNK protein using a rat focal transient cerebral ischemia model. Sakurazawa M, Katsura K, Saito M, Asoh S, Ohta S, Katayama Y. Brain Res; 2012 Jan 09; 1430():86-92. PubMed ID: 22099262 [Abstract] [Full Text] [Related]
10. TAT fusion proteins against ischemic stroke: current status and future perspectives. Kilic E, Kilic U, Hermann DM. Front Biosci; 2006 May 01; 11():1716-21. PubMed ID: 16368550 [Abstract] [Full Text] [Related]
12. Protective effects of intraperitoneal injection of TAT-SOD against focal cerebral ischemia/reperfusion injury in rats. Ye N, Liu S, Lin Y, Rao P. Life Sci; 2011 Dec 05; 89(23-24):868-74. PubMed ID: 21983418 [Abstract] [Full Text] [Related]
14. [Development of the protein therapeutics using the super anti-cell death factor FNK]. Ohta S. J Nippon Med Sch; 2003 Oct 05; 70(5):442-6. PubMed ID: 14578948 [Abstract] [Full Text] [Related]
15. Interleukin 3 prevents delayed neuronal death in the hippocampal CA1 field. Wen TC, Tanaka J, Peng H, Desaki J, Matsuda S, Maeda N, Fujita H, Sato K, Sakanaka M. J Exp Med; 1998 Aug 17; 188(4):635-49. PubMed ID: 9705946 [Abstract] [Full Text] [Related]